Novel insight into mechanisms of cholestatic liver injury.

Cholestasis results in a buildup of bile acids in serum and in hepatocytes. Early studies into the mechanisms of cholestatic liver injury strongly implicated bile acid-induced apoptosis as the major cause of hepatocellular injury. Recent work has focused both on the role of bile acids in cell signaling as well as the role of sterile inflammation in the pathophysiology. Advances in modern analytical methodology have allowed for more accurate measuring of bile acid concentrations in serum, liver, and bile to very low levels of detection. Interestingly, toxic bile acid levels are seemingly far lower than previously hypothesized. The initial hypothesis has been based largely upon the exposure of μmol/L concentrations of toxic bile acids and bile salts to primary hepatocytes in cell culture, the possibility that in vivo bile acid concentrations may be far lower than the observed in vitro toxicity has far reaching implications in the mechanism of injury. This review will focus on both how different bile acids and different bile acid concentrations can affect hepatocytes during cholestasis, and additionally provide insight into how these data support recent hypotheses that cholestatic liver injury may not occur through direct bile acid-induced apoptosis, but may involve largely inflammatory cell-mediated liver cell necrosis.

[1]  H. Jaeschke Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[2]  R. Straka,et al.  Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting , 2011, PloS one.

[3]  B. Winklhofer-Roob,et al.  Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. , 1995, Gastroenterology.

[4]  B. Kraupp,et al.  In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note , 1995, Hepatology.

[5]  Variant forms of cholestatic diseases involving small bile ducts in adults , 2000 .

[6]  H. Popper,et al.  Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation. , 1972, Gastroenterology.

[7]  S. Teng,et al.  Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis , 2007, British journal of pharmacology.

[8]  D. Billington,et al.  Effects of bile salts on the plasma membranes of isolated rat hepatocytes. , 1980, The Biochemical journal.

[9]  G. Gores,et al.  The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse , 2004, Journal of Pharmacology and Experimental Therapeutics.

[10]  C. Benz,et al.  Effect of tauroursodeoxycholic acid on bile acid‐induced apoptosis in primary human hepatocytes , 2000, European journal of clinical investigation.

[11]  J. Bezerra,et al.  Biliary atresia: will blocking inflammation tame the disease? , 2011, Annual review of medicine.

[12]  H. Jaeschke,et al.  Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[13]  G. Gores,et al.  NF-κB Is Activated in Cholestasis and Functions to Reduce Liver Injury , 2001 .

[14]  Jordi Muntané,et al.  Mecanismos de lesión hepatocelular , 2007 .

[15]  Bryan Goodwin,et al.  Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. , 2003, The Journal of clinical investigation.

[16]  P. Fisher,et al.  Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. , 2001, Molecular biology of the cell.

[17]  H. Jaeschke,et al.  Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. , 2003, Gastroenterology.

[18]  G. Gores,et al.  Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. , 1994, The Journal of clinical investigation.

[19]  D. Mangelsdorf,et al.  LXRS and FXR: the yin and yang of cholesterol and fat metabolism. , 2006, Annual review of physiology.

[20]  X. Adiconis,et al.  Fenofibrate Effect on Triglyceride and Postprandial Response of Apolipoprotein A5 Variants: The GOLDN Study , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[21]  H. Denk,et al.  Mechanism of cholestasis. 4. Structural and biochemical changes in the liver and serum in rats after bile duct ligation. , 1971, Gastroenterology.

[22]  Klaas Poelstra,et al.  Tauroursodeoxycholic acid protects rat hepatocytes from bile acid‐induced apoptosis via activation of survival pathways , 2004, Hepatology.

[23]  C. Steer,et al.  A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. , 1998, The Journal of clinical investigation.

[24]  W. Jochum,et al.  Characterization of time‐related changes after experimental bile duct ligation , 2008, The British journal of surgery.

[25]  K. Iwaisako,et al.  The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice , 2011, Hepatology.

[26]  C. Trautwein,et al.  Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. , 2003, Journal of hepatology.

[27]  H. Jaeschke,et al.  Oxidative Stress and the Pathogenesis of Cholestasis , 2010, Seminars in liver disease.

[28]  J. Schölmerich,et al.  Influence of Hydroxylation and Conjugation of Bile Salts on Their Membrane‐Damaging Properties‐Studies on Isolated Hepatocytes and Lipid Membrane Vesicles , 1984, Hepatology.

[29]  G. Gores,et al.  Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. , 1993, The Journal of clinical investigation.

[30]  M. Trauner,et al.  Fxr−/− mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids Published, JLR Papers in Press, December 4, 2005. , 2006, Journal of Lipid Research.

[31]  B. Balkau,et al.  A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. , 1991, The New England journal of medicine.

[32]  A. Baghdasaryan,et al.  Targeting Nuclear Bile Acid Receptors for Liver Disease , 2011, Digestive Diseases.

[33]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[34]  G. Gores,et al.  Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes. , 1995, The American journal of physiology.

[35]  C. Trautwein,et al.  Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. , 2002, Journal of hepatology.

[36]  H. Jaeschke,et al.  Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. , 1998, Journal of immunology.

[37]  R. Sokol,et al.  Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes , 1993, Hepatology.

[38]  H. Jaeschke,et al.  Effect of bile duct ligation on bile acid composition in mouse serum and liver , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[39]  W. Stremmel,et al.  Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. , 1998, Journal of hepatology.

[40]  Natalie J Torok,et al.  NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation , 2011, Hepatology.

[41]  P. Meier,et al.  Parallel decrease of Na+ ‐taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes , 1993, Hepatology.

[42]  K. Zatloukal,et al.  Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. , 2006, The American journal of pathology.

[43]  A. Farhood,et al.  Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[44]  F. Lammert,et al.  Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. , 2002, Gastroenterology.

[45]  H. Jaeschke,et al.  Reduced oncotic necrosis in fas receptor‐deficient C57BL/6J‐lpr mice after bile duct ligation , 2004, Hepatology.

[46]  P. Dent,et al.  Bile acids as regulatory molecules , 2009, Journal of Lipid Research.

[47]  M. Bilzer,et al.  Effects of hypochlorous acid and chloramines on vascular resistance, cell integrity, and biliary glutathione disulfide in the perfused rat liver: modulation by glutathione. , 1991, Journal of hepatology.

[48]  Hartmut Jaeschke,et al.  Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[49]  H. Jaeschke,et al.  Peroxynitrite-Induced Mitochondrial and Endonuclease-Mediated Nuclear DNA Damage in Acetaminophen Hepatotoxicity , 2005, Journal of Pharmacology and Experimental Therapeutics.

[50]  S. Bronk,et al.  Cytoprotection by fructose and other ketohexoses during bile salt‐induced apoptosis of hepatocytes , 1997, Hepatology.

[51]  H. Jaeschke,et al.  Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. , 2011, The American journal of pathology.

[52]  T. Willson,et al.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Zatloukal,et al.  Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. , 2009, The American journal of pathology.

[54]  J. Boyer,et al.  Ursodeoxycholic acid diminishes Fas‐ligand–induced apoptosis in mouse hepatocytes , 2002, Hepatology.

[55]  H. Jaeschke,et al.  Glutathione peroxidase–deficient mice are more susceptible to neutrophil‐mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress , 1999, Hepatology.

[56]  G. Gores,et al.  Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. , 2003, The Journal of clinical investigation.

[57]  K. Zatloukal,et al.  Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. , 2003, Gastroenterology.

[58]  Lixia Jin,et al.  Effect of Culture Time on the Basal Expression Levels of Drug Transporters in Sandwich-Cultured Primary Rat Hepatocytes , 2011, Drug Metabolism and Disposition.

[59]  T. Pusl,et al.  Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1. , 2008, Biochemical and biophysical research communications.

[60]  G. Gores,et al.  Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. , 1995, The Journal of pharmacology and experimental therapeutics.

[61]  C. Klaassen,et al.  Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[62]  P. Vandenabeele,et al.  Non‐specific effects of methyl ketone peptide inhibitors of caspases , 1999, FEBS letters.

[63]  H. Jaeschke,et al.  NADPH oxidase-derived oxidant stress is critical for neutrophil cytotoxicity during endotoxemia. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[64]  Songwen Zhang,et al.  Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis. , 2009, Journal of hepatology.

[65]  R. Sokol,et al.  Human Hepatic Mitochondria Generate Reactive Oxygen Species and Undergo the Permeability Transition in Response to Hydrophobic Bile Acids , 2005, Journal of pediatric gastroenterology and nutrition.

[66]  Hartmut Jaeschke,et al.  Apoptosis and necrosis in liver disease , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[67]  O. Chazouilleres,et al.  Chronic cholestatic diseases. , 2000, Journal of hepatology.

[68]  H. Jaeschke,et al.  Chlorotyrosine protein adducts are reliable biomarkers of neutrophil-induced cytotoxicity in vivo , 2004, Comparative hepatology.

[69]  U. Beuers,et al.  Bile Acid-induced Apoptosis in Hepatocytes Is Caspase-6-dependent* , 2009, Journal of Biological Chemistry.

[70]  C. Steer,et al.  Ursodeoxycholic Acid May Inhibit Deoxycholic Acid-Induced Apoptosis by Modulating Mitochondrial Transmembrane Potential and Reactive Oxygen Species Production , 1998, Molecular medicine.

[71]  M. Ebert,et al.  Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage. , 2011, The Biochemical journal.

[72]  K. Lindor,et al.  Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis , 2010, Current gastroenterology reports.

[73]  H. Jaeschke,et al.  Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct–ligated mice , 2003, Hepatology.

[74]  P. Galle,et al.  Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes , 1990, Hepatology.

[75]  G. Gores,et al.  Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.

[76]  G. Gores,et al.  The Bile Acid Glycochenodeoxycholate Induces TRAIL-Receptor 2/DR5 Expression and Apoptosis* , 2001, The Journal of Biological Chemistry.

[77]  J. Maher,et al.  Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. , 2000, Gastroenterology.

[78]  K. Zatloukal,et al.  Oncosis represents the main type of cell death in mouse models of cholestasis. , 2005, Journal of hepatology.

[79]  H. Jaeschke,et al.  Role of neutrophils in acute inflammatory liver injury , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[80]  M. Manns,et al.  The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis. , 2009, The American journal of pathology.

[81]  G. Gores,et al.  Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury. , 2001, The Journal of pharmacology and experimental therapeutics.

[82]  G. Dohm,et al.  Eccentric contractions decrease glucose transporter transcription rate, mRNA, and protein in skeletal muscle. , 1997, The American journal of physiology.

[83]  O. Briz,et al.  Bile-acid-induced cell injury and protection. , 2009, World journal of gastroenterology.

[84]  D. Brenner,et al.  Anti-fibrogenic strategies and the regression of fibrosis. , 2011, Best practice & research. Clinical gastroenterology.

[85]  R. Hiipakka,et al.  Selective activation of liver X receptor alpha by 6α-hydroxy bile acids and analogs , 2000, Steroids.

[86]  A. von Eckardstein,et al.  Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[87]  L. Schoenfield,et al.  Cholestasis induced by sodium taurolithocholate in isolated hamster liver. , 1971, The Journal of clinical investigation.

[88]  R. Sokol,et al.  Bile acid‐induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition , 2001, Hepatology.